U.S. Markets open in 3 hrs 40 mins
  • S&P Futures

    3,934.50
    +18.25 (+0.47%)
     
  • Dow Futures

    31,590.00
    +103.00 (+0.33%)
     
  • Nasdaq Futures

    12,215.50
    +75.00 (+0.62%)
     
  • Russell 2000 Futures

    1,770.00
    +8.30 (+0.47%)
     
  • Crude Oil

    107.26
    -0.36 (-0.33%)
     
  • Gold

    1,840.40
    +10.10 (+0.55%)
     
  • Silver

    21.50
    +0.37 (+1.75%)
     
  • EUR/USD

    1.0582
    +0.0023 (+0.2222%)
     
  • 10-Yr Bond

    3.1250
    0.0000 (0.00%)
     
  • Vix

    28.22
    -0.83 (-2.86%)
     
  • GBP/USD

    1.2294
    +0.0025 (+0.2004%)
     
  • USD/JPY

    135.0520
    -0.1180 (-0.0873%)
     
  • BTC-USD

    21,446.47
    +42.30 (+0.20%)
     
  • CMC Crypto 200

    468.00
    +14.11 (+3.11%)
     
  • FTSE 100

    7,264.71
    +55.90 (+0.78%)
     
  • Nikkei 225

    26,871.27
    +379.30 (+1.43%)
     

Why Agenus Stock Took Investors for a Wild Ride in 2021

·2 min read
Why Agenus Stock Took Investors for a Wild Ride in 2021
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of the small-cap immunotherapy company Agenus (NASDAQ: AGEN) were exceedingly volatile over the whole of 2021. Turning to the specifics, Agenus' stock first gained a healthy 55% during the first month of the year, before giving back all of these gains plus another 10%, according to data provided by S&P Global Market Intelligence . In May 2021, Agenus' stock went on a second major rally, with the drugmaker's shares more than doubling in value from their intra-year lows.